Literature DB >> 29741160

Adaptive deep brain stimulation for Parkinson's disease using motor cortex sensing.

Nicole C Swann1, Coralie de Hemptinne, Margaret C Thompson, Svjetlana Miocinovic, Andrew M Miller, Ro'ee Gilron, Jill L Ostrem, Howard J Chizeck, Philip A Starr.   

Abstract

OBJECTIVE: Contemporary deep brain stimulation (DBS) for Parkinson's disease is delivered continuously, and adjustments based on patient's changing symptoms must be made manually by a trained clinician. Patients may be subjected to energy intensive settings at times when they are not needed, possibly resulting in stimulation-induced adverse effects, such as dyskinesia. One solution is 'adaptive' DBS, in which stimulation is modified in real time based on neural signals that co-vary with the severity of motor signs or of stimulation-induced adverse effects. Here we show the feasibility of adaptive DBS using a fully implanted neural prosthesis. APPROACH: We demonstrate adaptive deep brain stimulation in two patients with Parkinson's disease using a fully implanted neural prosthesis that is enabled to utilize brain sensing to control stimulation amplitude (Activa PC  +  S). We used a cortical narrowband gamma (60-90 Hz) oscillation related to dyskinesia to decrease stimulation voltage when gamma oscillatory activity is high (indicating dyskinesia) and increase stimulation voltage when it is low. MAIN
RESULTS: We demonstrate the feasibility of 'adaptive deep brain stimulation' in two patients with Parkinson's disease. In short term in-clinic testing, energy savings were substantial (38%-45%), and therapeutic efficacy was maintained. SIGNIFICANCE: This is the first demonstration of adaptive DBS in Parkinson's disease using a fully implanted device and neural sensing. Our approach is distinct from other strategies utilizing basal ganglia signals for feedback control.

Entities:  

Mesh:

Year:  2018        PMID: 29741160      PMCID: PMC6021210          DOI: 10.1088/1741-2552/aabc9b

Source DB:  PubMed          Journal:  J Neural Eng        ISSN: 1741-2552            Impact factor:   5.379


  25 in total

1.  Calculating total electrical energy delivered by deep brain stimulation systems.

Authors:  Adam M Koss; Ron L Alterman; Michele Tagliati; Jay L Shils
Journal:  Ann Neurol       Date:  2005-07       Impact factor: 10.422

2.  Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.

Authors:  Andrea A Kühn; Andreas Kupsch; Gerd-Helge Schneider; Peter Brown
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

3.  Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease.

Authors:  Nicole C Swann; Coralie de Hemptinne; Svjetlana Miocinovic; Salman Qasim; Sarah S Wang; Nathan Ziman; Jill L Ostrem; Marta San Luciano; Nicholas B Galifianakis; Philip A Starr
Journal:  J Neurosci       Date:  2016-06-15       Impact factor: 6.167

4.  Spectral changes in cortical surface potentials during motor movement.

Authors:  Kai J Miller; Eric C Leuthardt; Gerwin Schalk; Rajesh P N Rao; Nicholas R Anderson; Daniel W Moran; John W Miller; Jeffrey G Ojemann
Journal:  J Neurosci       Date:  2007-02-28       Impact factor: 6.167

5.  High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance.

Authors:  Andrea A Kühn; Florian Kempf; Christof Brücke; Louise Gaynor Doyle; Irene Martinez-Torres; Alek Pogosyan; Thomas Trottenberg; Andreas Kupsch; Gerd-Helge Schneider; Marwan I Hariz; Wim Vandenberghe; Bart Nuttin; Peter Brown
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

6.  Thalamocortical network activity enables chronic tic detection in humans with Tourette syndrome.

Authors:  Jonathan B Shute; Michael S Okun; Enrico Opri; Rene Molina; P Justin Rossi; Daniel Martinez-Ramirez; Kelly D Foote; Aysegul Gunduz
Journal:  Neuroimage Clin       Date:  2016-06-25       Impact factor: 4.881

7.  Adaptive deep brain stimulation in a freely moving Parkinsonian patient.

Authors:  Manuela Rosa; Mattia Arlotti; Gianluca Ardolino; Filippo Cogiamanian; Sara Marceglia; Alessio Di Fonzo; Francesca Cortese; Paolo M Rampini; Alberto Priori
Journal:  Mov Disord       Date:  2015-05-21       Impact factor: 10.338

Review 8.  Adaptive Deep Brain Stimulation for Movement Disorders: The Long Road to Clinical Therapy.

Authors:  Anders Christian Meidahl; Gerd Tinkhauser; Damian Marc Herz; Hayriye Cagnan; Jean Debarros; Peter Brown
Journal:  Mov Disord       Date:  2017-06       Impact factor: 10.338

9.  The "brittle response" to Parkinson's disease medications: characterization and response to deep brain stimulation.

Authors:  Daniel Martinez-Ramirez; Juan Giugni; Vinata Vedam-Mai; Aparna Wagle Shukla; Irene A Malaty; Nikolaus R McFarland; Ramon L Rodriguez; Kelly D Foote; Michael S Okun
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

10.  Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation.

Authors:  Ashok Sriram; Kelly D Foote; Genko Oyama; Joshua Kwak; Pam R Zeilman; Michael S Okun
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-06-05
View more
  93 in total

1.  Chronic embedded cortico-thalamic closed-loop deep brain stimulation for the treatment of essential tremor.

Authors:  Enrico Opri; Stephanie Cernera; Rene Molina; Robert S Eisinger; Jackson N Cagle; Leonardo Almeida; Timothy Denison; Michael S Okun; Kelly D Foote; Aysegul Gunduz
Journal:  Sci Transl Med       Date:  2020-12-02       Impact factor: 17.956

2.  Core Concept: Can deep brain stimulation find success beyond Parkinson's disease?

Authors:  Helen H Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-12       Impact factor: 11.205

3.  Field potential 1/f activity in the subcallosal cingulate region as a candidate signal for monitoring deep brain stimulation for treatment-resistant depression.

Authors:  Ashan Veerakumar; Vineet Tiruvadi; Bryan Howell; Allison C Waters; Andrea L Crowell; Bradley Voytek; Patricio Riva-Posse; Lydia Denison; Justin K Rajendra; Johnathan A Edwards; Kelly R Bijanki; Ki Sueng Choi; Helen S Mayberg
Journal:  J Neurophysiol       Date:  2019-07-17       Impact factor: 2.714

4.  The Emerging Role of Biomarkers in Adaptive Modulation of Clinical Brain Stimulation.

Authors:  Kimberly B Hoang; Dennis A Turner
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

5.  The State of the NIH BRAIN Initiative.

Authors:  Walter Koroshetz; Joshua Gordon; Amy Adams; Andrea Beckel-Mitchener; James Churchill; Gregory Farber; Michelle Freund; Jim Gnadt; Nina S Hsu; Nicholas Langhals; Sarah Lisanby; Guoying Liu; Grace C Y Peng; Khara Ramos; Michael Steinmetz; Edmund Talley; Samantha White
Journal:  J Neurosci       Date:  2018-06-19       Impact factor: 6.167

Review 6.  Debugging Adaptive Deep Brain Stimulation for Parkinson's Disease.

Authors:  Simon Little; Peter Brown
Journal:  Mov Disord       Date:  2020-02-10       Impact factor: 10.338

7.  Understanding Parkinson's disease and deep brain stimulation: Role of monkey models.

Authors:  Jerrold L Vitek; Luke A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 8.  Toward Electrophysiology-Based Intelligent Adaptive Deep Brain Stimulation for Movement Disorders.

Authors:  Andrea A Kühn; R Mark Richardson; Wolf-Julian Neumann; Robert S Turner; Benjamin Blankertz; Tom Mitchell
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

Review 9.  Clinical neuroprosthetics: Today and tomorrow.

Authors:  Morgan B Lee; Daniel R Kramer; Terrance Peng; Michael F Barbaro; Charles Y Liu; Spencer Kellis; Brian Lee
Journal:  J Clin Neurosci       Date:  2019-07-30       Impact factor: 1.961

Review 10.  Developing Collaborative Platforms to Advance Neurotechnology and Its Translation.

Authors:  David A Borton; Heather E Dawes; Gregory A Worrell; Philip A Starr; Timothy J Denison
Journal:  Neuron       Date:  2020-10-28       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.